BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26531312)

  • 1. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
    Sie AS; van Zelst-Stams WA; Spruijt L; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    Fam Cancer; 2014 Jun; 13(2):143-51. PubMed ID: 24068317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    BMC Womens Health; 2012 May; 12():12. PubMed ID: 22569005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer.
    Voorwinden JS; Jaspers JP
    J Genet Couns; 2016 Jun; 25(3):495-503. PubMed ID: 26475052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
    Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
    Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
    Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.
    Schlich-Bakker KJ; Ausems MG; Schipper M; Ten Kroode HF; Wárlám-Rodenhuis CC; van den Bout J
    Breast Cancer Res Treat; 2008 Jun; 109(3):507-14. PubMed ID: 17674198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland.
    O'Shea R; Meany M; Carroll C; Cody N; Healy D; Green A; Lynch SA
    J Genet Couns; 2016 Jun; 25(3):422-31. PubMed ID: 26407988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
    Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
    JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
    Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
    Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors.
    Kasting ML; Conley CC; Hoogland AI; Scherr CL; Kim J; Thapa R; Reblin M; Meade CD; Lee MC; Pal T; Quinn GP; Vadaparampil ST
    Psychooncology; 2019 May; 28(5):980-988. PubMed ID: 30883986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.
    Hooker GW; Leventhal KG; DeMarco T; Peshkin BN; Finch C; Wahl E; Joines JR; Brown K; Valdimarsdottir H; Schwartz MD
    Med Decis Making; 2011; 31(3):412-21. PubMed ID: 20876346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.
    Nilsson MP; Nilsson ED; Borg Å; Brandberg Y; Silfverberg B; Loman N
    Breast Cancer Res Treat; 2019 Jan; 173(2):313-318. PubMed ID: 30311024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer.
    Eismann S; Vetter L; Keller M; Bruckner T; Golatta M; Hennings A; Domschke C; Dikow N; Sohn C; Heil J; Schott S
    Arch Gynecol Obstet; 2016 Nov; 294(5):1011-1018. PubMed ID: 27282618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.